Docusate Plus Senna is a Oral Tablet, Film Coated in the Human Otc Drug category. It is labeled and distributed by Safecor Health, Llc. The primary component is Docusate Sodium; Sennosides A And B.
| Product ID | 48433-304_8d0c5a61-4d68-44d1-a600-0261c221daa9 |
| NDC | 48433-304 |
| Product Type | Human Otc Drug |
| Proprietary Name | Docusate Plus Senna |
| Generic Name | Docusate Sodium-sennosides |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2014-09-30 |
| Marketing Category | OTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL |
| Application Number | part334 |
| Labeler Name | Safecor Health, LLC |
| Substance Name | DOCUSATE SODIUM; SENNOSIDES A AND B |
| Active Ingredient Strength | 50 mg/1; min/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2014-11-10 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | OTC monograph not final |
| Application Number | part334 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2014-09-30 |
| Marketing End Date | 2019-11-11 |
| Marketing Category | OTC monograph not final |
| Application Number | part334 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2014-11-10 |
| Marketing End Date | 2019-11-11 |
| Marketing Category | OTC monograph not final |
| Application Number | part334 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2014-09-30 |
| Marketing End Date | 2019-11-11 |
| Ingredient | Strength |
|---|---|
| DOCUSATE SODIUM | 50 mg/1 |
| SPL SET ID: | 9e0d04b2-bef8-4adf-aee4-c0fd2d62c84f |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 48433-304 | Docusate Plus Senna | DOCUSATE SODIUM-SENNOSIDES |
| 49483-081 | SENNA TIME S | DOCUSATE SODIUM-SENNOSIDES |